美国私人保险孕妇Tdap疫苗接种趋势(2009-2016)
该回顾性分析基于2009-2016年MarketScan数据,评估私人保险孕妇Tdap疫苗接种率变化。孕期接种率从2009年0.4%升至2012年6.2%,2016年达53.2%,且27-36周接种比例从<10%增至近90%。未接种者中77.7%在27-36周有孕期相关医疗就诊,存在大量错过接种机会。
要点
- 孕期Tdap接种率从2009年0.4%升至2016年53.2%,2012年指南修订后增幅最大。
- 接种者中27-36周接种比例从2009年<10%升至2016年近90%,多集中在27-32周。
- 未接种孕妇中77.7%在27-36周有孕期相关医疗索赔,提示错过接种机会。
核心结论
- 2009至2016年私人保险孕妇Tdap接种率显著上升,指南修订后增幅最大。
- 多数未接种孕妇在孕期有医疗就诊,存在提高接种率和婴儿保护的潜力。
研究设计与样本
- 回顾性分析2009-2016年MarketScan数据,纳入15-49岁连续参保且分娩活产儿的私人保险孕妇。
- 评估Tdap接种覆盖率及接种时机,采用多因素logistic回归分析与27-36周接种相关的因素。
主要发现
- 孕期Tdap接种率从2009年0.4%升至2012年6.2%,2016年达53.2%。
- 接种者中27-36周接种比例从2009年<10%升至2016年近90%,多发生在27-32周。
- 年长、居住于大都市统计区、非南部地区及持有按人头付费保险计划的女性更可能在27-36周接种。
- 未孕期接种的女性中77.7%在27-36周有孕期相关医疗索赔。
关键数值与推荐
- 2012年10月ACIP修订建议:每次妊娠均接种一剂Tdap,理想时间为27-36周。
临床怎么用
- 孕27-36周是接种Tdap关键窗口,应结合孕期就诊主动评估接种状态。
- 对未接种孕妇,尤其27-36周有就诊者,应利用机会补种以保护婴儿。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Infants younger than 6 months are at increased risk of complications and mortality from pertussis infection. In October 2012, the Advisory Committee on Immunization Practices revised its recommendation to include a Tdap dose during each pregnancy, ideally between 27 and 36 weeks gestation. OBJECTIVE: Assess trends in Tdap vaccination coverage among privately insured pregnant women from 2009 to 2016 including timing of Tdap vaccination (before, during, or after pregnancy), trimester of vaccination for women vaccinated during pregnancy, and missed vaccination opportunities for unvaccinated women. Identify factors associated with vaccination during the optimal period of 27-36 weeks gestation. STUDY DESIGN: Retrospective analysis of privately insured women 15-49 years who delivered live births during 2009-2016 conducted using 2009-2016 MarketScan data. Tdap vaccination coverage and the timing of Tdap vaccine administration were assessed for women continuously enrolled from 6 months before pregnancy to 1 month after delivery. Multivariable logistic regression was performed to identify factors independently associated with receipt of Tdap vaccine at 27-36 weeks gestation. RESULTS: Tdap vaccination coverage during pregnancy increased from 0.4% in 2009 to 6.2% in 2012 and to 53.2% in 2016. The proportion of vaccinated women receiving Tdap at 27-36 weeks gestation increased from <10% in 2009 to nearly 90% in 2016, with most vaccination occurring at 27-32 weeks gestation. Women of older age, residing in a metropolitan statistical area, residing outside the South, and having a capitated health insurance plan were more likely to receive Tdap at 27-36 weeks gestation than their counterparts. Among women not vaccinated during pregnancy, 77.7% had a pregnancy-related medical claim between 27 and 36 weeks gestation. CONCLUSION: Tdap vaccination coverage during pregnancy increased significantly from 2009 to 2016, with the greatest increase occurring after the revised Advisory Committee on Immunization Practices recommendation. Most women who did not receive Tdap vaccine had a missed vaccination opportunity during pregnancy, indicating potential for much higher vaccination coverage and consequent infant protection against pertussis.
引用
- Zhou F, Xu J, Black CL, et al. Trends in Tdap vaccination among privately insured pregnant women in the United States, 2009-2016. Vaccine. 2019. PMID: 30826146. doi:10.1016/j.vaccine.2019.02.042
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。